cached image

57 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Béchet S, O'Sullivan S, Yssel J, Fagan SG, Dev KK. Fingolimod rescues demyelination in a mouse model of Krabbe's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32127495 DOI: 10.1523/JNEUROSCI.2346-19.2020  0.342
2019 Velasco-Estevez M, Rolle SO, Mampay M, Dev KK, Sheridan GK. Piezo1 regulates calcium oscillations and cytokine release from astrocytes. Glia. PMID 31433095 DOI: 10.1002/glia.23709  0.313
2019 Neyman S, Braunewell KH, O'Connell KE, Dev KK, Manahan-Vaughan D. Inhibition of the Interaction Between Group I Metabotropic Glutamate Receptors and PDZ-Domain Proteins Prevents Hippocampal Long-Term Depression, but Not Long-Term Potentiation. Frontiers in Synaptic Neuroscience. 11: 13. PMID 31057390 DOI: 10.3389/Fnsyn.2019.00013  0.372
2018 Dutta P, Dargahi L, O'Connell KE, Bolia A, Ozkan B, Sailer AW, Dev KK. A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson's disease. Neuroscience Letters. PMID 29496607 DOI: 10.1016/j.neulet.2018.02.055  0.37
2018 O'Sullivan SA, O'Sullivan C, Healy LM, Dev KK, Sheridan GK. Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia. Journal of Neurochemistry. PMID 29377126 DOI: 10.1111/jnc.14313  0.381
2018 Rutkowska A, Shimshek DR, Sailer AW, Dev KK. EBI2 regulates pro-inflammatory signalling and cytokine release in astrocytes. Neuropharmacology. PMID 29374507 DOI: 10.1016/j.neuropharm.2018.01.029  0.338
2017 Rutkowska A, Sailer AW, Dev KK. EBI2 receptor regulates myelin development and inhibits LPC-induced demyelination. Journal of Neuroinflammation. 14: 250. PMID 29246262 DOI: 10.1186/s12974-017-1025-0  0.369
2017 Misslin C, Velasco-Estevez M, Albert M, O'Sullivan SA, Dev KK. Phospholipase A2 is involved in galactosylsphingosine-induced astrocyte toxicity, neuronal damage and demyelination. Plos One. 12: e0187217. PMID 29095858 DOI: 10.1371/journal.pone.0187217  0.328
2017 O'Sullivan SA, Dev KK. The chemokine fractalkine (CX3CL1) attenuates H2O2-induced demyelination in cerebellar slices. Journal of Neuroinflammation. 14: 159. PMID 28810923 DOI: 10.1186/s12974-017-0932-4  0.301
2017 Dev KK, Irving AJ. Lipid sensing G protein-coupled receptors in the CNS. Neuropharmacology. 113: 595-596. PMID 27986103 DOI: 10.1016/j.neuropharm.2016.10.030  0.32
2016 Dev KK. Editorial (Thematic Issue: Common Receptor Signalling in Glial & Immune Cells). Current Drug Targets. 17: 1828. PMID 27991401 DOI: 10.2174/138945011716161108230929  0.322
2016 O'Sullivan S, Dev KK. Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases. Neuropharmacology. PMID 27825807 DOI: 10.1016/j.neuropharm.2016.11.006  0.364
2016 O'Sullivan SA, Gasparini F, Mir AK, Dev KK. Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes. Journal of Neuroinflammation. 13: 189. PMID 27549131 DOI: 10.1186/s12974-016-0659-7  0.329
2016 Rutkowska A, O'Sullivan SA, Christen I, Zhang J, Sailer AW, Dev KK. The EBI2 signalling pathway plays a role in cellular crosstalk between astrocytes and macrophages. Scientific Reports. 6: 25520. PMID 27166278 DOI: 10.1038/srep25520  0.331
2016 Rutkowska A, Dev KK, Sailer AW. The role of the oxysterol/EBI2 pathway in the immune and central nervous systems. Current Drug Targets. PMID 26898310 DOI: 10.2174/1389450117666160217123042  0.353
2015 O'Sullivan C, Dev KK. Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling. Journal of Cell Science. 128: 3878-87. PMID 26359302 DOI: 10.1242/jcs.169342  0.337
2015 Rutkowska A, Preuss I, Gessier F, Sailer AW, Dev KK. EBI2 regulates intracellular signaling and migration in human astrocyte. Glia. 63: 341-51. PMID 25297897 DOI: 10.1002/glia.22757  0.371
2014 Pritchard AJ, Mir AK, Dev KK. Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures. Plos One. 9: e99444. PMID 24911000 DOI: 10.1371/journal.pone.0099444  0.345
2014 Dutta P, O'Connell KE, Ozkan SB, Sailer AW, Dev KK. The protein interacting with C-kinase (PICK1) interacts with and attenuates parkin-associated endothelial-like (PAEL) receptor-mediated cell death. Journal of Neurochemistry. 130: 360-73. PMID 24749734 DOI: 10.1111/Jnc.12741  0.383
2014 Shrestha R, Millington O, Brewer J, Dev KK, Bushell TJ. Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways. Neuropharmacology. 76: 184-93. PMID 23831681 DOI: 10.1016/J.Neuropharm.2013.06.025  0.335
2013 O'Sullivan C, Dev KK. The structure and function of the S1P1 receptor. Trends in Pharmacological Sciences. 34: 401-12. PMID 23763867 DOI: 10.1016/j.tips.2013.05.002  0.387
2013 Healy LM, Sheridan GK, Pritchard AJ, Rutkowska A, Mullershausen F, Dev KK. Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes. British Journal of Pharmacology. 169: 1114-29. PMID 23587004 DOI: 10.1111/bph.12207  0.351
2013 Doucet MV, Levine H, Dev KK, Harkin A. Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1575-84. PMID 23446451 DOI: 10.1038/Npp.2013.57  0.301
2013 Pritchard AJ, Dev KK. The role of sphingosine 1-phosphate receptors in the treatment of demyelinating diseases Future Neurology. 8: 569-581. DOI: 10.2217/fnl.13.32  0.378
2012 Bolia A, Gerek ZN, Keskin O, Banu Ozkan S, Dev KK. The binding affinities of proteins interacting with the PDZ domain of PICK1. Proteins. 80: 1393-408. PMID 22275068 DOI: 10.1002/Prot.24034  0.337
2012 Doucet MV, Harkin A, Dev KK. The PSD-95/nNOS complex: new drugs for depression? Pharmacology & Therapeutics. 133: 218-29. PMID 22133842 DOI: 10.1016/J.Pharmthera.2011.11.005  0.31
2012 Sheridan GK, Dev KK. S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures. Glia. 60: 382-92. PMID 22108845 DOI: 10.1002/glia.22272  0.384
2010 Mattes H, Dev KK, Bouhelal R, Barske C, Gasparini F, Guerini D, Mir AK, Orain D, Osinde M, Picard A, Dubois C, Tasdelen E, Haessig S. Design and synthesis of selective and potent orally active S1P5 agonists. Chemmedchem. 5: 1693-6. PMID 20815011 DOI: 10.1002/cmdc.201000253  0.325
2008 Dev KK, Mullershausen F, Mattes H, Kuhn RR, Bilbe G, Hoyer D, Mir A. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacology & Therapeutics. 117: 77-93. PMID 17961662 DOI: 10.1016/J.Pharmthera.2007.08.005  0.332
2008 Cryan JF, Dev KK. Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders Handbook of Behavioral Neuroscience. 17: 269-301. DOI: 10.1016/S1569-7339(07)00013-6  0.503
2007 Senechal Y, Kelly PH, Cryan JF, Natt F, Dev KK. Amyloid precursor protein knockdown by siRNA impairs spontaneous alternation in adult mice. Journal of Neurochemistry. 102: 1928-40. PMID 17540010 DOI: 10.1111/j.1471-4159.2007.04672.x  0.446
2007 Mullershausen F, Craveiro LM, Shin Y, Cortes-Cros M, Bassilana F, Osinde M, Wishart WL, Guerini D, Thallmair M, Schwab ME, Sivasankaran R, Seuwen K, Dev KK. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. Journal of Neurochemistry. 102: 1151-61. PMID 17488279 DOI: 10.1111/j.1471-4159.2007.4629.x  0.371
2007 Osinde M, Mullershausen F, Dev KK. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology. 52: 1210-8. PMID 17379261 DOI: 10.1016/j.neuropharm.2006.11.010  0.368
2007 Dev KK. PDZ domain protein-protein interactions: a case study with PICK1. Current Topics in Medicinal Chemistry. 7: 3-20. PMID 17266593 DOI: 10.2174/156802607779318343  0.34
2006 Senechal Y, Larmet Y, Dev KK. Unraveling in vivo functions of amyloid precursor protein: insights from knockout and knockdown studies. Neuro-Degenerative Diseases. 3: 134-47. PMID 16954700 DOI: 10.1159/000094772  0.308
2005 Madsen KL, Beuming T, Niv MY, Chang CW, Dev KK, Weinstein H, Gether U. Molecular determinants for the complex binding specificity of the PDZ domain in PICK1. The Journal of Biological Chemistry. 280: 20539-48. PMID 15774468 DOI: 10.1074/Jbc.M500577200  0.303
2004 Dev KK, Nakanishi S, Henley JM. The PDZ domain of PICK1 differentially accepts protein kinase C-alpha and GluR2 as interacting ligands. The Journal of Biological Chemistry. 279: 41393-7. PMID 15247289 DOI: 10.1074/Jbc.M404499200  0.337
2004 Terashima A, Cotton L, Dev KK, Meyer G, Zaman S, Duprat F, Henley JM, Collingridge GL, Isaac JT. Regulation of synaptic strength and AMPA receptor subunit composition by PICK1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5381-90. PMID 15190111 DOI: 10.1523/Jneurosci.4378-03.2004  0.368
2003 Dev KK, van der Putten H, Sommer B, Rovelli G. Part I: parkin-associated proteins and Parkinson's disease. Neuropharmacology. 45: 1-13. PMID 12814656 DOI: 10.1016/S0028-3908(02)00337-4  0.344
2003 Cho K, Francis JC, Hirbec H, Dev K, Brown MW, Henley JM, Bashir ZI. Regulation of kainate receptors by protein kinase C and metabotropic glutamate receptors. The Journal of Physiology. 548: 723-30. PMID 12640005 DOI: 10.1111/J.1469-7793.2003.00723.X  0.387
2003 Finney N, Walther F, Mantel PY, Stauffer D, Rovelli G, Dev KK. The cellular protein level of parkin is regulated by its ubiquitin-like domain. The Journal of Biological Chemistry. 278: 16054-8. PMID 12621021 DOI: 10.1074/jbc.C300051200  0.308
2003 Hirbec H, Francis JC, Lauri SE, Braithwaite SP, Coussen F, Mulle C, Dev KK, Coutinho V, Meyer G, Isaac JT, Collingridge GL, Henley JM, Couthino V. Rapid and differential regulation of AMPA and kainate receptors at hippocampal mossy fibre synapses by PICK1 and GRIP. Neuron. 37: 625-38. PMID 12597860 DOI: 10.1016/S0896-6273(02)01191-1  0.344
2002 Hirbec H, Perestenko O, Nishimune A, Meyer G, Nakanishi S, Henley JM, Dev KK. The PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor subtypes. Analysis of PDZ binding motifs. The Journal of Biological Chemistry. 277: 15221-4. PMID 11891216 DOI: 10.1074/Jbc.C200112200  0.392
2001 Dev KK, Nakanishi S, Henley JM. Regulation of mglu(7) receptors by proteins that interact with the intracellular C-terminus. Trends in Pharmacological Sciences. 22: 355-61. PMID 11431030 DOI: 10.1016/S0165-6147(00)01684-9  0.393
2001 Perestenko O, Hirbec H, Dev K, Nishimune A, Meyer G, Francis JC, Henley JM. Use of GST pull-down assays to identify new interactions between the PICK1 and GRIP proteins and the glutamate receptors Biochemical Society Transactions. 29: A89-A89. DOI: 10.1042/Bst029A089  0.357
2001 Francis JC, Hirbec H, Braithwaite SP, Dev K, Henley JM. Characterisation of The Interaction Between The Kainate Receptor Subunit, GluR5-2b and PICK1 Biochemical Society Transactions. 29: A88-A88. DOI: 10.1042/Bst029A088  0.328
2000 Daw MI, Chittajallu R, Bortolotto ZA, Dev KK, Duprat F, Henley JM, Collingridge GL, Isaac JT. PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron. 28: 873-86. PMID 11163273 DOI: 10.1016/S0896-6273(00)00160-4  0.347
2000 Dev KK, Nakajima Y, Kitano J, Braithwaite SP, Henley JM, Nakanishi S. PICK1 Interacts with and Regulates PKC Phosphorylation of mGLUR7 The Journal of Neuroscience. 20: 7252-7257. DOI: 10.1523/Jneurosci.20-19-07252.2000  0.389
1999 Dev KK, Nishimune A, Henley JM, Nakanishi S. The protein kinase C alpha binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits. Neuropharmacology. 38: 635-44. PMID 10340301 DOI: 10.1016/S0028-3908(98)00230-5  0.353
1998 Dev KK, Henley JM. The regulation of AMPA receptor-binding sites. Molecular Neurobiology. 17: 33-58. PMID 9887445 DOI: 10.1007/Bf02802023  0.387
1998 Dev KK, Honoré T, Henley JM. Different effects of phospholipase A2 on agonist binding to hippocampal, cortical and recombinant homomeric alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Neuroscience Letters. 246: 25-8. PMID 9622199 DOI: 10.1016/S0304-3940(98)00200-6  0.38
1997 Dev KK, Foged C, Andersen H, Honoré T, Henley JM. High-affinity binding sites for 125I-labelled pancreatic secretory phospholipase A2 in rat brain. Brain Research. Molecular Brain Research. 49: 120-6. PMID 9387871 DOI: 10.1016/S0169-328X(97)00134-4  0.307
1996 Dev KK, Roberts PJ, Henley JM. Characterisation of the interaction between guanyl nucleotides and AMPA receptors in rat brain. Neuropharmacology. 35: 1583-93. PMID 9025106 DOI: 10.1016/S0028-3908(96)00123-2  0.35
1996 Dev KK, Petersen V, Honoré T, Henley JM. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain. Journal of Neurochemistry. 67: 2609-12. PMID 8931496 DOI: 10.1046/J.1471-4159.1996.67062609.X  0.317
1996 Chittajallu R, Vignes M, Dev KK, Barnes JM, Collingridge GL, Henley JM. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature. 379: 78-81. PMID 8538745 DOI: 10.1038/379078A0  0.334
1995 Dev KK, Honoré T, Henley JM. Phospholipase A2 down-regulates the affinity of [3H]AMPA binding to rat cortical membranes. Journal of Neurochemistry. 65: 184-91. PMID 7540662 DOI: 10.1046/J.1471-4159.1995.65010184.X  0.315
1994 Barnes JM, Dev KK, Henley JM. Cyclothiazide unmasks AMPA-evoked stimulation of [3H]-L-glutamate release from rat hippocampal synaptosomes. British Journal of Pharmacology. 113: 339-41. PMID 7530567 DOI: 10.1111/J.1476-5381.1994.Tb16902.X  0.305
Show low-probability matches.